1. Home
  2. OPRA vs QURE Comparison

OPRA vs QURE Comparison

Compare OPRA & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opera Limited

OPRA

Opera Limited

HOLD

Current Price

$17.16

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$17.61

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRA
QURE
Founded
1996
1998
Country
Norway
Netherlands
Employees
N/A
248
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
OPRA
QURE
Price
$17.16
$17.61
Analyst Decision
Strong Buy
Buy
Analyst Count
2
14
Target Price
$22.75
$44.92
AVG Volume (30 Days)
453.0K
1.6M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
4.70%
N/A
EPS Growth
N/A
29.67
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$21.29
$126.12
Revenue Next Year
$15.34
$200.43
P/E Ratio
$13.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.71
$8.73
52 Week High
$21.06
$71.50

Technical Indicators

Market Signals
Indicator
OPRA
QURE
Relative Strength Index (RSI) 71.06 53.07
Support Level $15.55 $13.47
Resistance Level $17.72 $18.37
Average True Range (ATR) 0.58 1.33
MACD 0.25 0.27
Stochastic Oscillator 90.53 87.86

Price Performance

Historical Comparison
OPRA
QURE

About OPRA Opera Limited

Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: